Study Overview


NCTId: NCT02467686

Status: Unknown status

Condition: Sexuality

Study Type: Interventional

Sponsor: Irmandade da Santa Casa de Misericordia de Sao Paulo

Study Description


The purpose of this study is to evaluate the Cimicifuga racemosa effects on the sexuality of women with Breast cancer using tamoxifen or aromatase inhibitor through questionnaires.


For the study will be recruited 60 women treated with breast cancer, using tamoxifen or aromatase inhibitor, are in menopause, hot flashes and has with or without sexual life. They will answer the questionnaires: Kupperman, World Health Organization Quality of Life (WHOQOL) and those sexually active will have Female Sexual Function Index (FSFI). The control group will have 30 patients using tamoxifen alone or inhibitor. The other group will have 30 patients receiving tamoxifen or inhibitor and will start with 2 tablets per day of dry extract of Cimicifuga racemosa. They will be followed for 6 months and answer questionnaires at the first visit, 3-month and 6-month follow-up.



Inclusion Criteria:

Menopausal women with breast cancer treated and using tamoxifen or aromatase inhibitor.
With hot flashes and with or without active sexual life.

Exclusion Criteria:

Women did not have breast cancer
do not use tamoxifen or aromatase inhibitor
not in menopause and not have hot flashes

Healthy Volunteers: Accepts Healthy Volunteers

Gender: Female

Min Age: 48 Years

Max Age: 68 Years


Carolina Furtado Macruz


Sao Paulo



Carolina Macruz



[email protected]

Written by